GNH USA

Europe — EMA

Paclitaxel Accord

Paclitaxel, the active ingredient in Paclitaxel Accord, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It treats various solid tumours in adult oncology patients.

Request sourcing

1
Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It treats various solid tumours in adult oncology patients. GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Paclitaxel used for?

Paclitaxel is used primarily for solid tumours that share a common micro‑t​​t ​   

- Breast Cancer: It   ...

What are the side effects of Paclitaxel?

Common ...

What precautions apply to Paclitaxel?

....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Paclitaxel
Route
Intravenous Use
Manufacturer
Accord Healthcare S.L.U.
Origin
EU

Related products